Anti-GFAP antibody - Astrocyte Marker (Ab7260)
Glial fibrillary acidic protein, GFAP
详细信息
特异性
Specifically recognizes mammalian GFAP on western blots and immunocytochemically. Detects a band of 55kDa corresponding to GFAP and also a GFAP derived 48kDa band. Some customers have successfully used ab7260 on Zebrafish lysates; however we have conflicting data to suggest that not all batches will be suitable for work on Zebrafish. For further information, please contact Abcam Scientific Support.
背景信息
Find all reagents to label astrocytes in our " Astrocytes markers guide ". Anti-GFAP antibody (ab7260) is a rabbit polyclonal antibody and is validated for use in ICC/IF, IHC (PFA fixed), IHC-P, IP and WB. Anti-GFAP antibody (ab7260) was first used in a scientific publication in 2006 and has been cited over 1203 times in peer reviewed journals. It's performance in Western blot, immunofluorescence and IHC in mouse and rat samples is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-GFAP antibody (ab7260) has high sensitivity and specificity. Anti-GFAP antibody (ab7260) has 103 independent reviews from customers. Anti-GFAP antibody (ab7260) specifically detects GFAP (UniProt ID: P14136; Molecular weight: 50kDa) and is sold in 50 µL selling sizes. GFAP (Glial Fibrillary Acidic Protein) is a key marker in neuro research, particularly for its role in identifying astrocyte activity. It is predominantly expressed in astrocytes, the most abundant glial cells in the brain and spinal cord. Altered GFAP levels are associated with various neurological conditions, including Alzheimer's disease (AD), traumatic brain injury (TBI) and multiple sclerosis (MS). Researchers use GFAP to assess astrocytic response and neuroinflammation, making it essential for understanding the extent of brain injury and the progression of neurodegenerative diseases.
文献引用 (1524)
Biomimetic membrane-coating zinc sulfide nanoparticles for anti-inflammatory combined neuroprotective therapy for spinal cord injury.
仿生膜包覆硫化锌纳米颗粒用于脊髓损伤的抗炎联合神经保护疗法。
Hydrogel with cell-cell adhesion cues enhances neural regeneration.
具有细胞间粘附信号的水凝胶可促进神经再生。
Molecular heterogeneity of the non-human primate cochlea.
非人灵长类动物耳蜗的分子异质性。
Anti-TLR2 immunotherapy modulates neuron-to-oligodendrocyte propagation of α-synuclein in mouse and human models.
抗 TLR2 免疫疗法可调节小鼠和人类模型中 α-突触核蛋白从神经元到少突胶质细胞的传播。
Remodeling synaptic connections via engineered neuron-astrocyte interactions.
通过工程化神经元-星形胶质细胞相互作用重塑突触连接。
Discovery of a Novel and Potent Kir4.1 Inhibitor as a Safe and Rapid-Onset Antidepressant Agent in Mice.
发现一种新型强效 Kir4.1 抑制剂,可作为小鼠安全快速起效的抗抑郁药。
Elevated Apolipoprotein E Expression in Hippocampal Microglia Drives Temporal Lobe Epilepsy Progression.
海马小胶质细胞中载脂蛋白 E 表达升高驱动颞叶癫痫进展。
Oral Celastrol Nanomedicine Targeting Intestinal Antigen-Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut-Retina Axis.
口服雷公藤内酯醇纳米药物靶向肠道抗原呈递细胞,通过肠-视网膜轴有效缓解自身免疫性葡萄膜炎。
Distinct neuronal alterations distinguish two subtypes of sporadic Creutzfeldt-Jakob disease with shared dysfunctional pathways.
散发性克雅氏病的两个亚型具有不同的神经元改变,但它们都存在共同的功能障碍通路。
cRGD-Functionalized macrophage extracellular vesicles loaded with GSK2033 enhance T cell antitumor immunity in GBM by disrupting the LXR/ABCA1-Mediated Myelin lipid transfer axis.
载有 GSK2033 的 cRGD 功能化巨噬细胞细胞外囊泡通过破坏 LXR/ABCA1 介导的髓鞘脂质转移轴增强 GBM 中的 T 细胞抗肿瘤免疫力。
- 1
- 2
- 3
- 4
- 5
- 6
- 153